BELVIQ

This brand name is authorized in Brazil, United States

Active ingredients

The drug BELVIQ contains one active pharmaceutical ingredient (API):

1 Lorcaserin UNII REV26SR2B4 - LORCASERIN HYDROCHLORIDE HEMIHYDRATE

Lorcaserin is believed to decrease food consumption and promote satiety by selectively activating 5-HT2C receptors on anorexigenic pro-opiomelanocortin neurons located in the hypothalamus. The exact mechanism of action is not known. It is used as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients. Read about Lorcaserin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
BELVIQ / BELVIQ XR Film-coated tablet / Extended-release tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A08AA11		A Alimentary tract and metabolism → A08 Antiobesity preparations, excl. diet products → A08A Antiobesity preparations, excl. diet products → A08AA Centrally acting antiobesity products
Discover more medicines within A08AA11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 508020050130617, 508020050130717, 508020050130817, 508020050130917
Country: US	FDA, National Drug Code	Identifier(s): 62856-529, 62856-535